The sphingosine kinase 2 inhibitor ABC294640 displays anti‐non‐small cell lung cancer activities in vitro and in vivo-Reference-Cited by-同舟云学术

The sphingosine kinase 2 inhibitor ABC294640 displays anti‐non‐small cell lung cancer activities in vitro and in vivo

Published:2018-01-04 Issue:10 Volume:142 Page:2153-2162
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Dai Lu¹²,Smith Charles D.³,Foroozesh Maryam⁴,Miele Lucio¹,Qin Zhiqiang¹²^ORCID

Affiliation:

1. Department of GeneticsLouisiana State University Health Sciences Center, Louisiana Cancer Research Center, 1700 Tulane Ave.New Orleans LA

2. Department of Pediatrics, Research Center for Translational Medicine and Key Laboratory of ArrhythmiasEast Hospital, Tongji University School of MedicineShanghai200120 China

3. Apogee Biotechnology CorporationHummelstown PA

4. Department of ChemistryXavier University of Louisiana, 1 Drexel DriveNew Orleans LA

Funder

National Institutes of Health

Tulane University

U.S. Department of Defense

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31234

Reference38 articles.

1. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

2. A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

3. Nivolumab in NSCLC: latest evidence and clinical potential

4. Treating with checkpoint inhibitors‐figure $1 million per patient;Andrews A.;Am Health Drug Benefits,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Characterization, Spectroscopic Profile, Molecular Docking, ADMET Properties, Molecular Dynamics Simulation Studies, and Molecular Mechanics Generalized Born Surface Area Analysis of 5-(Adamantan-1-yl)-4-butyl-2,4-dihydro-3H-1,2,4-triazole-3-thione as a Potential COX Inhibitor;ACS Omega;2024-06-05

2. Developing new ceramide analogs against non-small cell lung cancer (NSCLC);American Journal of Cancer Research;2024

3. Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy;International Journal of Molecular Sciences;2023-11-29

4. miR-137 is a diagnostic tumor-suppressive miRNA that targets SPHK2 to promote M1-type tumor-associated macrophage polarization;EXP THER MED;2023

5. Synthesis, Spectroscopic Analysis, Molecular Docking, Molecular Dynamics Simulation of 5-(Adamantan-1-yl)-4-(3-Chlorophenyl)-2,4-Dihydro-3H-1,2,4-Triazole-3-Thione, a Potential Anti-proliferative Agent;Polycyclic Aromatic Compounds;2023-06-08